| Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review JG Chiabrando, A Bonaventura, A Vecchié, GF Wohlford, AG Mauro, ... Journal of the American College of Cardiology 75 (1), 76-92, 2020 | 447 | 2020 |
| Interleukin‐1 blockade inhibits the acute inflammatory response in patients with ST‐segment–elevation myocardial infarction A Abbate, CR Trankle, LF Buckley, MJ Lipinski, D Appleton, D Kadariya, ... Journal of the American Heart Association 9 (5), e014941, 2020 | 295 | 2020 |
| IL-1 blockade in patients with heart failure with preserved ejection fraction: results from DHART2 BW Van Tassell, CR Trankle, JM Canada, S Carbone, L Buckley, ... Circulation: Heart Failure 11 (8), e005036, 2018 | 211 | 2018 |
| Effect of canakinumab vs placebo on survival without invasive mechanical ventilation in patients hospitalized with severe COVID-19: a randomized clinical trial R Caricchio, A Abbate, I Gordeev, J Meng, PY Hsue, T Neogi, R Arduino, ... Jama 326 (3), 230-239, 2021 | 190 | 2021 |
| Intensive versus standard blood pressure control in SPRINT-eligible participants of ACCORD-BP LF Buckley, DL Dixon, GF Wohlford IV, DS Wijesinghe, WL Baker, ... Diabetes Care 40 (12), 1733-1738, 2017 | 145 | 2017 |
| Phase 1b, randomized, double-blinded, dose escalation, single-center, repeat dose safety and pharmacodynamics study of the oral nlrp3 inhibitor dapansutrile in subjects with … GF Wohlford, BW Van Tassell, HE Billingsley, D Kadariya, S Carbone, ... Journal of cardiovascular pharmacology 77 (1), 49-60, 2021 | 141 | 2021 |
| Interleukin-1 blockade with anakinra and heart failure following ST-segment elevation myocardial infarction: results from a pooled analysis of the VCUART clinical trials A Abbate, GF Wohlford, MG Del Buono, JG Chiabrando, R Markley, ... European Heart Journal-Cardiovascular Pharmacotherapy 8 (5), 503-510, 2022 | 112 | 2022 |
| Mavrilimumab in patients with severe COVID-19 pneumonia and systemic hyperinflammation (MASH-COVID): an investigator initiated, multicentre, double-blind, randomised, placebo … PC Cremer, A Abbate, K Hudock, C McWilliams, J Mehta, SY Chang, ... The Lancet Rheumatology 3 (6), e410-e418, 2021 | 71 | 2021 |
| Rationale and design of the Virginia Commonwealth University–Anakinra Remodeling Trial‐3 (VCU‐ART3): A randomized, placebo‐controlled, double‐blinded, multicenter study BW Van Tassell, MJ Lipinski, D Appleton, CS Roberts, MC Kontos, ... Clinical cardiology 41 (8), 1004-1008, 2018 | 65 | 2018 |
| Role for anti-cytokine therapies in severe coronavirus disease 2019 LF Buckley, GF Wohlford, C Ting, A Alahmed, BW Van Tassell, A Abbate, ... Critical care explorations 2 (8), e0178, 2020 | 61 | 2020 |
| Alirocumab in acute myocardial infarction: results from the Virginia commonwealth university alirocumab response trial (VCU-AlirocRT) CR Trankle, G Wohlford, LF Buckley, D Kadariya, K Ravindra, R Markley, ... Journal of cardiovascular pharmacology 74 (3), 266-269, 2019 | 53 | 2019 |
| Clinical presentation and outcomes of acute pericarditis in a large urban hospital in the United States of America A Vecchié, JG Chiabrando, MS Dell, A Bonaventura, AG Mauro, ... Chest 158 (6), 2556-2567, 2020 | 49 | 2020 |
| Effect of intensive blood pressure control in patients with type 2 diabetes mellitus over 9 years of follow‐up: a subgroup analysis of high‐risk ACCORDION trial participants LF Buckley, DL Dixon, GF Wohlford IV, DS Wijesinghe, WL Baker, ... Diabetes, Obesity and Metabolism 20 (6), 1499-1502, 2018 | 47 | 2018 |
| Stenting techniques for coronary bifurcation lesions: Evidence from a network meta‐analysis of randomized clinical trials JG Chiabrando, M Lombardi, GM Vescovo, GF Wohlford, RA Koenig, ... Catheterization and Cardiovascular Interventions 97 (3), E306-E318, 2021 | 37 | 2021 |
| Recent updates on the use of PCSK9 inhibitors in patients with atherosclerotic cardiovascular disease DL Dixon, LG Pamulapati, JD Bucheit, EM Sisson, SR Smith, CJ Kim, ... Current atherosclerosis reports 21 (5), 16, 2019 | 35 | 2019 |
| C-reactive protein and N-terminal pro-brain natriuretic peptide levels correlate with impaired cardiorespiratory fitness in patients with heart failure across a wide range of … J Van Wezenbeek, JM Canada, K Ravindra, S Carbone, CR Trankle, ... Frontiers in cardiovascular medicine 5, 178, 2018 | 33 | 2018 |
| Acute effects of interleukin-1 blockade using anakinra in patients with acute pericarditis GF Wohlford, LF Buckley, A Vecchié, D Kadariya, R Markley, CR Trankle, ... Journal of cardiovascular pharmacology 76 (1), 50-52, 2020 | 32 | 2020 |
| Metabolic modulation predicts heart failure tests performance D Contaifer Jr, LF Buckley, G Wohlford, NG Kumar, JM Morriss, ... PLoS One 14 (6), e0218153, 2019 | 31 | 2019 |
| 2025 concise clinical guidance: an ACC expert consensus statement on the diagnosis and management of pericarditis: a report of the American College of Cardiology Solution Set … TKM Wang, AL Klein, PC Cremer, M Imazio, S Kohnstamm, SA Luis, ... Journal of the American College of Cardiology 86 (25), 2691-2719, 2025 | 30 | 2025 |
| Pharmacokinetics of L-triiodothyronine in patients undergoing thyroid hormone therapy withdrawal B Van Tassell, GF Wohlford IV, JD Linderman, S Smith, S Yavuz, F Pucino, ... Thyroid 29 (10), 1371-1379, 2019 | 30 | 2019 |
